Hybribio is one of the pioneer biotech companies specialized in in-vitro diagnostic products with fully integrated one-stop operation chain from R&D, manufacturing, sales & marketing to after-sales technical support service. As of year 2014, over 2 million tests of 21 HPV Genotyping test has been performed in China. Furthermore, we are the sole company collaborating with the Ministry of Health in Chinese Government to establish the first HPV database system in China.
Currently, more than 1200 hospitals and medical institutes in China has been adopted our HPV diagnostic technology and more than 20 countries around the globe have been using our products for clinical and research purposes.
Working along with partners from different countries, our sales and marketing teams aim for providing an effective strategic marketing plan to suit into different markets. Over 150 scientists and technical personnel stationed in China and Hong Kong providing on-site technical training and after-sales technical service support is what we care of.
As of today, more than 20 countries worldwide are collaborating with Hybribio for HPV diagnostic detection including Asia Pacific and South-East Asia Region, Middle East Region, South America Region, European Region and African Region. Hybribio’s products were widely recognized in the foreign scientific research and medical institutions.